(Q36425959)

English

Clinical application of development of nonantibiotic macrolides that correct inflammation-driven immune dysfunction in inflammatory skin diseases

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

6 references

22 June 2019

17 June 2019

11 November 2019

13 November 2019

24 July 2020

11 September 2020

Clinical application of development of nonantibiotic macrolides that correct inflammation-driven immune dysfunction in inflammatory skin diseases (English)

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

0 references

6 references

22 June 2019

17 June 2019

11 November 2019

13 November 2019

24 July 2020

11 September 2020

1 reference

11 November 2019

polycyclic compound

1 reference

13 November 2019

1 reference

24 July 2020

1 reference

11 September 2020

author name string

Carmen Rodriguez-Cerdeira

1

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Elena Sanchez-Blanco

2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Alberto Molares-Vila

3

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

publication date

1 November 2012

7 references

Europe PubMed Central

PMC publication ID

14 August 2017

22 June 2019

17 June 2019

11 November 2019

13 November 2019

24 July 2020

11 September 2020

Mediators of Inflammation

7 references

Europe PubMed Central

PMC publication ID

14 August 2017

22 June 2019

17 June 2019

11 November 2019

13 November 2019

24 July 2020

11 September 2020

2012

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

563709

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

copyright license

Creative Commons Attribution 3.0 Unported

6 references

Europe PubMed Central

22 June 2019

Europe PubMed Central

17 June 2019

Europe PubMed Central

11 November 2019

Europe PubMed Central

13 November 2019

Europe PubMed Central

24 July 2020

Europe PubMed Central

11 September 2020

copyright status

0 references

on focus list of Wikimedia project

0 references

Chronic autoimmune urticaria.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Analysis of the pharmacodynamic activity of the mTOR inhibitor ridaforolimus (AP23573, MK-8669) in a phase 1 clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Systematic review: the role of tacrolimus in the management of Crohn's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

In vivo vitiligo induction and therapy model: double-blind, randomized clinical trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Topical calcineurin inhibitors in the treatment of atopic dermatitis - an update on safety issues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Randomized comparison of topical betamethasone valerate foam, intralesional triamcinolone acetonide and tacrolimus ointment in management of localized alopecia areata

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Ridaforolimus (AP23573; MK-8669), a potent mTOR inhibitor, has broad antitumor activity and can be optimally administered using intermittent dosing regimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

IL-2, IL-5, TNF-α and IFN-γ mRNA expression in epidermal keratinocytes of systemic lupus erythematosus skin lesions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Current and future directions in mammalian target of rapamycin inhibitors development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Topical immunomodulators for management of oral mucosal conditions, a systematic review; part I: calcineurin inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Pathogenesis of oral lichen planus - a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Innovative use of topical calcineurin inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Accelerated wound healing by mTOR activation in genetically defined mouse models.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Topical calcineurin inhibitors in systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Kinase targets in renal-cell carcinomas: reassessing the old and discovering the new.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Long-term blood vessel removal with combined laser and topical rapamycin antiangiogenic therapy: implications for effective port wine stain treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Topical tacrolimus and pimecrolimus in the treatment of oral lichen planus: an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Topical calcineurin inhibitors for the treatment of vulvar dermatoses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Graft-versus-host disease prophylaxis with tacrolimus and mycophenolate mofetil in HLA-matched nonmyeloablative transplant recipients is associated with very low incidence of GVHD and nonrelapse mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Tacrolimus in hematopoietic stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Pimecrolimus in dermatology.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Treatment of intertriginous psoriasis: from the Medical Board of the National Psoriasis Foundation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Fifteen years of clinical studies and clinical practice in renal transplantation: reviewing outcomes with de novo use of sirolimus in combination with cyclosporine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Innate immunity in inflammatory bowel disease: a disease hypothesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Systemic ciclosporin and tacrolimus in dermatology.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

The Propionibacterium acnes genome: from the laboratory to the clinic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Unravelling the pathogenesis of inflammatory bowel disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Risk factors for impaired wound healing in sirolimus-treated renal transplant recipients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Severe psoriasis treated with a new macrolide: everolimus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

The protean face of sarcoidosis revisited

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

CCI-779 inhibits rhabdomyosarcoma xenograft growth by an antiangiogenic mechanism linked to the targeting of mTOR/Hif-1alpha/VEGF signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Managing the symptoms of Behçet's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Pimecrolimus: a review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

The macrolide immunosuppressants in dermatology: mechanisms of action.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Tacrolimus in dermatology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

FK506 potently inhibits T cell activation induced TNF-alpha and IL-1beta production in vitro by human peripheral blood mononuclear cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

KEGG: kyoto encyclopedia of genes and genomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Eukaryotic Translation Initiation Factor 4E Regulates Expression of Cyclin D1 at Transcriptional and Post-transcriptional Levels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

30 September 2017

Cutaneous sarcoidosis successfully treated with topical tacrolimus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

28 June 2018

Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

28 June 2018

Segmental vitiligo: a randomized controlled trial to evaluate efficacy and safety of 0.1% tacrolimus ointment vs 0.05% fluticasone propionate cream.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

21 September 2018

Pimecrolimus 1% cream for the treatment of rosacea.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

21 September 2018

Trends in pediatric psoriasis outpatient health care delivery in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

21 September 2018

Topical tacrolimus for parastomal pyoderma gangrenosum: a report of two cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

21 September 2018

Pimecrolimus versus placebo in genital aphthous ulcers of Behcet's disease: a randomized double-blind controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

21 September 2018

Mometasone cream versus pimecrolimus cream for the treatment of childhood localized vitiligo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

21 September 2018

Severe atopic dermatitis treated with everolimus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

21 September 2018

Topical tacrolimus for the treatment of localized, idiopathic, newly diagnosed pyoderma gangrenosum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

21 September 2018

Efficacy of oral tacrolimus on intestinal Behcet's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

21 September 2018

Pimecrolimus 1% cream versus betamethasone 17-valerate 0.1% cream in the treatment of facial discoid lupus erythematosus: a double-blind, randomized pilot study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

21 September 2018

Frontal fibrosing alopecia: treatment with oral dutasteride and topical pimecrolimus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

21 September 2018

Oral lichen planus and treatment with topical tacrolimus rinse

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

21 September 2018

Clinical efficacy of tacrolimus in rosacea

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

21 September 2018

Successful treatment of severe pyoderma gangrenosum with pimecrolimus cream 1%.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

21 September 2018

Penetration of topically applied tacrolimus into the aqueous humor in Behçet's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

21 September 2018

Successful treatment of patch type mycosis fungoides with tacrolimus ointment 0.1%.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

21 September 2018

A comparative study of sirolimus tablet versus oral solution for prophylaxis of acute renal allograft rejection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

21 September 2018

Efficacy and tolerability of three different doses of oral pimecrolimus in the treatment of moderate to severe atopic dermatitis: a randomized controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

21 September 2018

Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

21 September 2018

Effects of calcineurin inhibitors on an in vitro assay for chronic urticaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

21 September 2018

Treatment of cutaneous chronic graft-versus-host disease with topical pimecrolimus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

21 September 2018

Treatment of psoriasis with topical sirolimus: preclinical development and a randomized, double-blind trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

21 September 2018

Identification of mTOR as a novel bifunctional target in chronic myeloid leukemia: dissection of growth-inhibitory and VEGF-suppressive effects of rapamycin in leukemic cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

21 September 2018

Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

21 September 2018

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

21 September 2018

Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system. (Comparison with steroids).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

21 September 2018

Rapamycin inhibits constitutive p70s6k phosphorylation, cell proliferation, and colony formation in small cell lung cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507315

21 September 2018

Macrolides in chronic inflammatory skin disorders

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F563709

21 January 2018

Palmoplantar Pustular Psoriasis: Clinical and Video Thermographic Evaluation Before and After Topical Tacrolimus Treatment

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F563709

21 January 2018

Single center prospective study of tacrolimus efficacy and safety in the treatment of various manifestations in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F563709

21 January 2018

Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatory bowel diseases and arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23258954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pustular penile pyoderma gangrenosum successfully treated with topical tacrolimus ointment

1 reference

https://pubmed.ncbi.nlm.nih.gov/23258954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overview of efficacy and safety of tacrolimus ointment in patients with atopic dermatitis in Asia and other areas

1 reference

https://pubmed.ncbi.nlm.nih.gov/23258954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined effects of FK506 (tacrolimus) and cyclophosphamide on atypical B220+ T cells, cytokine gene expression and disease activity in MRL/MpJ-lpr/lpr mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/23258954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful therapy of refractory graft versus host disease with tacrolimus and Psoralen plus ultraviolet light

1 reference

https://pubmed.ncbi.nlm.nih.gov/23258954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic plaque psoriasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23258954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topical tacrolimus: treatment failure in a patient with alopecia areata

1 reference

https://pubmed.ncbi.nlm.nih.gov/23258954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tacrolimus in the treatment of chronic and refractory late-onset immune-mediated adverse effects related to silicone injections

1 reference

https://pubmed.ncbi.nlm.nih.gov/23258954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized study of topical tacrolimus ointment as possible treatment for resistant idiopathic pruritus ani

1 reference

https://pubmed.ncbi.nlm.nih.gov/23258954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topical tacrolimus for the treatment of psoriasis on the face, genitalia, intertriginous areas and corporal plaques

1 reference

https://pubmed.ncbi.nlm.nih.gov/23258954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Open-label, pilot study examining sequential therapy with oral tacrolimus and topical tacrolimus for severe atopic dermatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23258954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Behçet's disease in women]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23258954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The comparison of treatment with clobetasol propionate 0.05% and topical pimecrolimus 1% treatment in the treatment of alopecia areata

1 reference

https://pubmed.ncbi.nlm.nih.gov/23258954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Remission of an iatrogenic Kaposi sarcoma in a patient with myasthenia gravis after switching immunosuppressive therapy to the mTOR inhibitor everolimus]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23258954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tacrolimus 0.1% vs mometasone furoate topical treatment in allergic contact hand eczema: a prospective randomized clinical study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23258954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

First human face transplantation: 5 years outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/23258954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful treatment with topical tacrolimus in four cases of discoid lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/23258954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel 12-membered non-antibiotic macrolides from erythromycin A; EM900 series as novel leads for anti-inflammatory and/or immunomodulatory agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/23258954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1155/2012/563709

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36425959&oldid=1518727512"